Simon has over six years of professional trading experience across FX, commodities and equities. He has a strong passion for financial markets and is particularly focused on price action trading
Shares of IQ-AI Ltd (LON: IQAI) rallied 10.6% after the company announced a major breakthrough in its artificial intelligence (AI) driven imaging technology that generates simulated brain images without contrast agents.
The images generated by the AI models bear close similarity to actual images generated in real-world scenarios with contrast.
IQ-AI will now submit complete datasets of the images to a team of neuro-radiologists for assessment to determine the quality of the simulated images.
The firm will also run a quantitative, voxel-wise, statistical comparison to measure the images’ accuracy when compared to real-world images.
Lastly, the selected images will be deployed in various sites for comparison against actual clinical data to obtain regulatory approval if successful.
Trevor Brown, IQ-AI’s CEO, said: “Qualitatively, as illustrated in the link above, the recent improvements are so remarkable that ‘wow’ is the only word which seems appropriate. We will continue to update shareholders on this important project as developments unfold.”
IQ-AI’s share price is still trading above the resistance level we outlined in our last article about the imaging biometrics company on 6th January supporting our bullish thesis. Today’s rally represents a bounce off the crucial support level.
IQ-AI share price
IQ-AI shares rallied 010.58% to trade at 9.40p having risen from Wednesday’s closing price of 8.50p.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .